Tibet Aim Pharm. (SZ:002826) Xin Lang Cai Jing·2025-10-29 02:30Core Insights - Yiming Pharmaceutical (002826.SZ) reported its Q3 2025 results, highlighting significant institutional investment growth [1] Institutional Holdings - As of October 28, 2025, five institutional investors disclosed holdings in Yiming Pharmaceutical, totaling 48.1693 million shares, which represents 25.26% of the company's total share capital [1] - The institutional holding percentage increased by 24.33 percentage points compared to the previous quarter [1] Public Fund Activity - One new public fund disclosed its holdings this quarter, namely Wanji Zhongzheng 2000 Index Enhanced A [1] - Eleven public funds were not disclosed in this quarter compared to the previous one, including notable funds such as CITIC Securities Quantitative Selection A and Jianxin Zhongzheng 500 Index Enhanced A [1]